Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Clausen

Showing results (341-350 of 356) with videos related to

Pageof 36
Sort By:
Molecular Pharmacology|December 15, 2015
Pharmacology and Structural Analysis of Ligand Binding to the Orthosteric Site of Glutamate-Like GluD2 ReceptorsAnders S Kristensen, Kasper B Hansen, Peter Naur, et al.
ACS Chemical Neuroscience|July 9, 2015
Identification of the First Highly Subtype-Selective Inhibitor of Human GABA Transporter GAT3Maria Damgaard, Anas Al-Khawaja, Stine B Vogensen, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2004
First demonstration of a functional role for central nervous system betaine/{gamma}-aminobutyric acid transporter (mGAT2) based on synergistic anticonvulsant action among inhibitors of mGAT1 and mGAT2H Steve White, William P Watson, Suzanne L Hansen, et al.
Chemmedchem|January 24, 2012
Structure-activity relationships for negative allosteric mGluR5 modulatorsBirgitte H Kaae, Kasper Harpsøe, Trine Kvist, et al.
Journal of Medicinal Chemistry|April 4, 2019
Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor LigandsStefano Sainas, Piero Temperini, Jill C Farnsworth, et al.
Journal of Medicinal Chemistry|October 10, 2017
Structure-Activity Relationship, Pharmacological Characterization, and Molecular Modeling of Noncompetitive Inhibitors of the Betaine/γ-Aminobutyric Acid Transporter 1 (BGT1)Lars Jørgensen, Anas Al-Khawaja, Stefanie Kickinger, et al.
Journal of Medicinal Chemistry|April 26, 2007
A tetrazolyl-substituted subtype-selective AMPA receptor agonistStine B Vogensen, Karla Frydenvang, Jeremy R Greenwood, et al.
Molecular Pharmacology|July 12, 2007
Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptorsKevin Erreger, Matthew T Geballe, Anders Kristensen, et al.
The Journal of General Physiology|December 3, 2025
Novel binding mode for negative allosteric NMDA receptor modulatorsJames S Lotti, Jed T Syrenne, Avery J Benton, et al.
Epilepsy Research|April 5, 2011
Deletion of the betaine-GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult miceA C Lehre, N M Rowley, Y Zhou, et al.
Pageof 36

Showing results (341-350 of 356) with videos related to

Sort By:
Pageof 36
Molecular Pharmacology|December 15, 2015
Pharmacology and Structural Analysis of Ligand Binding to the Orthosteric Site of Glutamate-Like GluD2 ReceptorsAnders S Kristensen, Kasper B Hansen, Peter Naur, et al.
ACS Chemical Neuroscience|July 9, 2015
Identification of the First Highly Subtype-Selective Inhibitor of Human GABA Transporter GAT3Maria Damgaard, Anas Al-Khawaja, Stine B Vogensen, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 20, 2004
First demonstration of a functional role for central nervous system betaine/{gamma}-aminobutyric acid transporter (mGAT2) based on synergistic anticonvulsant action among inhibitors of mGAT1 and mGAT2H Steve White, William P Watson, Suzanne L Hansen, et al.
Chemmedchem|January 24, 2012
Structure-activity relationships for negative allosteric mGluR5 modulatorsBirgitte H Kaae, Kasper Harpsøe, Trine Kvist, et al.
Journal of Medicinal Chemistry|April 4, 2019
Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor LigandsStefano Sainas, Piero Temperini, Jill C Farnsworth, et al.
Journal of Medicinal Chemistry|October 10, 2017
Structure-Activity Relationship, Pharmacological Characterization, and Molecular Modeling of Noncompetitive Inhibitors of the Betaine/γ-Aminobutyric Acid Transporter 1 (BGT1)Lars Jørgensen, Anas Al-Khawaja, Stefanie Kickinger, et al.
Journal of Medicinal Chemistry|April 26, 2007
A tetrazolyl-substituted subtype-selective AMPA receptor agonistStine B Vogensen, Karla Frydenvang, Jeremy R Greenwood, et al.
Molecular Pharmacology|July 12, 2007
Subunit-specific agonist activity at NR2A-, NR2B-, NR2C-, and NR2D-containing N-methyl-D-aspartate glutamate receptorsKevin Erreger, Matthew T Geballe, Anders Kristensen, et al.
The Journal of General Physiology|December 3, 2025
Novel binding mode for negative allosteric NMDA receptor modulatorsJames S Lotti, Jed T Syrenne, Avery J Benton, et al.
Epilepsy Research|April 5, 2011
Deletion of the betaine-GABA transporter (BGT1; slc6a12) gene does not affect seizure thresholds of adult miceA C Lehre, N M Rowley, Y Zhou, et al.
Pageof 36